LeafNLP Demos
Back to explore

Report #2881681

Received Jan 13, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Jan 8, 2026
Onset
Jan 8, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNKH4K3S—

Symptoms (1)

Exposure during pregnancy

Symptom narrative

Drug exposure during pregnancy; This non-serious prospective pregnancy case was reported by a nurse via registry and described the occurrence of vaccine exposure during pregnancy in a 35-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number H4K3S) for prophylaxis. On 08-JAN-2026, the patient received Boostrix. On 08-JAN-2026, an unknown time after receiving Boostrix, the patient experienced vaccine exposure during pregnancy (Verbatim: Drug exposure during pregnancy). The outcome of the vaccine exposure during pregnancy was not applicable. Pregnancy exposure: Pregnancy Exposure (Boostrix): Trimester unknown Pregnancy Outcome: Pregnancy was ongoing